Sandbox: HCL therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
'''[[Interferon alpha]] alone'''<br> | '''[[Interferon alpha]] alone'''<br> | ||
'''Alternative purine analogue {{withorwithout}} rituximab'''</div>|E02=<div style="width: 13em; padding:1em;">'''Follow-up and close observation'''</div>}} | '''Alternative purine analogue {{withorwithout}} rituximab'''</div>|E02=<div style="width: 13em; padding:1em;">'''Follow-up and close observation'''</div>}} | ||
{{familytree | | | | | | |!| | | |!| | | | | | | | | | | }} | |||
{{familytree | | | | | | |!| | | |!| | | | | | | | | | | }} | |||
{{familytree | | | | | | E02 | | E01 | | | | | | | | | | |E01=<div style="width: 17em; padding:1em;text-align:center">'''No evidence of complete response'''</div>|E02=<div style="width: 13em; padding:1em;">'''Follow-up and close observation'''</div>}} | |||
{{familytree/end}} | {{familytree/end}} | ||
<br> | <br> | ||
Revision as of 02:05, 30 October 2015
Initial patients evaluation | |||||||||||||||||||||||||||||||||||||||||||
History Physical examination Complete blood count | |||||||||||||||||||||||||||||||||||||||||||
Asymptomatic patients with no therapeutic indications | Symptomatic patients or evidence of therapeutic indications | ||||||||||||||||||||||||||||||||||||||||||
Patients managed by observation and close follow-up | |||||||||||||||||||||||||||||||||||||||||||
Complete response | No evidence of complete response | ||||||||||||||||||||||||||||||||||||||||||
Follow-up and close observation | Retuximab alone | ||||||||||||||||||||||||||||||||||||||||||
Follow-up and close observation | No evidence of complete response | ||||||||||||||||||||||||||||||||||||||||||